The South Korean Financial Services Commission’s KRW 15.4 billion ($12.6 million) fine to global pharmaceutical company Celltrion is a warning to others to comply with accounting standards and transfer pricing rules.
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Leanna covers transfer pricing developments and court rulings. She writes about jurisdictions' alignment with OECD standards, profit shifting via TP arrangements, and other topics including tax reforms across the world. Leanna also reports on anti-money laundering legislation and the BEPS project.